Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 24Gastrointestinal 16Genitourinary 13Other 8Head & Neck 7Other hematologic neoplasm 6Thoracic 5Lymphoid 5Plasma cell 4Gynecologic 4CNS 4Tumor-Agnostic 2Sarcoma 2Other solid neoplasm 2Endocrine 2Other neoplasm 1Myeloid 1Dermatologic 1

Conditions

Multiple Myeloma 3Smoldering Multiple Myeloma 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1

Interventions

Dexamethasone 882Bortezomib 481Lenalidomide 467Cyclophosphamide 367Melphalan 276Calcium Dobesilate 265daratumumab 241pomalidomide 216carfilzomib 188fludarabine phosphate 141fludarabine 137Thalidomide 125Peripheral Blood Stem Cell Transplantation 120Filgrastim 115ixazomib 94Mycophenolic Acid 91Granulocyte Colony-Stimulating Factor 90Busulfan 89Whole-Body Irradiation 88dexamethasone acetate 87Tacrolimus 79dexamethasone 21-phosphate 74isatuximab 70Cyclosporine 68auricularum 67Prednisone 67elotuzumab 63belantamab mafodotin 60Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Resistance Training × Plasma cell × Clear all
NCT05763563 2026-03-31

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Neoplasms, Plasma Cell

NCT07045727 2026-03-30

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Mayo Clinic

Phase NA Recruiting
20 enrolled
Plasma cell

Multiple Myeloma

NCT05312255 2025-12-01

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Recruiting
175 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT03793907 2023-04-10

Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Completed
65 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡